Skip to main content
. 2022 Jan 30;12(7):3809–3827. doi: 10.1039/d1ra06149f

Fig. 2. The rationale for compound designing. (A) The structural alignment of docking poses of top three molecules of VS (1.0 million in-house e-compounds) with the crystal structure PDB id. 4I5I. (B) The structure of the “chemical-core” identified for designing the ligands of Schemes 1 and 2.

Fig. 2